Quanterix(US:QTRX)2025-11-10 21:30Financial Performance - Quanterix reported Q3 2025 revenue of $40.2 million[9], a 12% increase compared to $35.8 million in Q3 2024[18] - The company's GAAP gross margin was 42.8% in Q3 2025, compared to 56.3% in Q3 2024[18] - Adjusted EBITDA margin was -29% in Q3 2025, compared to -15% in Q3 2024[18] - Adjusted cash usage for Q3 2025 was $16.1 million, compared to $3.3 million in Q3 2024[18] - The company expects to end 2025 with approximately $120 million in cash and no debt[9] Synergies and Cost Reduction - Synergies and cost actions are expected to result in cash flow breakeven performance in 2026[9] - The company has implemented $67 million of the total $85 million annualized cost reduction[11] Business Outlook - Full year 2025 revenue is guided to be between $130 million and $135 million, including ~$30 million contribution from Spatial[20] - GAAP and Adjusted Gross Margin (Non-GAAP) between 45% to 47%[21] - Adjusted cash usage is projected to be $34 million to $38 million for the full year 2025[22] Alzheimer's Diagnostics Business - The company is making solid progress in advancing its Alzheimer's Diagnostics Business[13]